InternaView membership options
UK National Screening Committee position statement on surrogate outcomes in cancer screening trials
VIP articleIn this article (BMJ 2026;393:e629407; doi:10.1136/bmj-2026-629407) the first initial of D Gareth Evans was omitted. The online version has been corrected.
ME
MedScopeGlobal Editorial
June 3, 2026
InternaVIP
Evidence-based clinical briefing
UK National Screening Committee
MedScope VIP
This article is reserved for VIP subscribers. Upgrade for full access, an ad-free reading experience, and priority clinical alerts.
Doporučený obsah
Články
- Mapping the intellectual structure and emerging trends of neurophobia research in health professions education
- Mapping the intellectual structure and emerging trends of neurophobia research in health professions education
- Synergistic Renoprotective Effects of Moderate-Intensity Resistance Training and Vitamin D Supplementation on a Type 2 Diabetic Nephropathy Rat Model
- Diagnostika a screening u nejčastějších symptomů
Studie
- RhePort 1.3 enhances early identification of inflammatory rheumatic diseases: a prospective study in German rheumatology settings
- Upskilling Rheumatology Occupational Therapists in Work Rehabilitation: An Evaluation of a Job Retention Vocational Rehabilitation Training Course (the Workwell Trial)
- Satisfaction with telemedicine versus in-person visits in rheumatology: a noninferiority randomised controlled trial